Cagnoni Pablo J

CEO and President, DirectorRubius Therapeutics, Inc. (RUBY) · full profile →Form 4 · filed Feb 1, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$44K
Net Open-Market Flow
-$44K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2022Sell(S)7K$6.57$44K36K
Jan 29, 2022Option exercise(M)21K42K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2022Grant(A)100K$0100K
Jan 31, 2022Grant(A)365K$0365K
Jan 29, 2022Option exercise(M)21K$064K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-22-000697) within minutes of acceptance. Every field above traces to the original document. Verify it directly: